Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Pain
RCT	30 people, aged 21–70 years, with gout of the knee, ankle, wrist, big toe, or elbow In review	Proportion of people showing at least a 50% reduction in pain (pain assessed on a 4-point scale: 'disappeared', 'improved by at least 50%', 'unchanged or improved by <50%', or 'increased') 1 day 10/15 (67%) with tenoxicam 4/15 (26%) with placebo	P <0.05	Effect size not calculated	tenoxicam
Tenderness
RCT	30 people, aged 21–70 years, with gout of the knee, ankle, wrist, big toe, or elbow In review	Proportion of people showing at least a 50% reduction in tenderness (assessed on a 4-point scale: 'disappeared', 'improved by at least 50%', 'unchanged or improved by <50%', or 'increased') 1 day 6/15 (40%) with tenoxicam 1/15 (7%) with placebo	P <0.05	Effect size not calculated	tenoxicam
Pain on mobilisation
RCT	30 people, aged 21–70 years, with gout of the knee, ankle, wrist, big toe, or elbow In review	Proportion of people showing at least a 50% reduction in pain on mobilisation (assessed on a 4-point scale: 'disappeared', 'improved by at least 50%', 'unchanged or improved by <50%', or 'increased') 1 day 4/15 (27%) with tenoxicam 1/15 (7%) with placebo	P <0.05	Effect size not calculated	tenoxicam
Physician-rated efficacy
RCT	30 people, aged 21–70 years, with gout of the knee, ankle, wrist, big toe, or elbow In review	Proportion of people with improvement rated as 'good or excellent' 4 days 7/15 (47%) with tenoxicam 4/15 (27%) with placebo	Reported as not significant P value not reported		Not significant